QIF-T0111
mediumGVS motion illusion injection
Tier 5 — Theoretical (Modeled / Simulated)
Legacy status: THEORETICAL
Technique Details
- Tactic
- QIF-N.MD
- Status
- THEORETICAL
- Bands
- I0, N1, N2, N3, N4
✚ Therapeutic Application
Galvanic vestibular stimulation (GVS) delivering subthreshold or suprathreshold current to mastoid processes to induce illusory motion perception or postural sway
Clinical Analog
Galvanic vestibular stimulation (GVS) therapy
Treats
- bilateral vestibular hypofunction
- Parkinson's gait freezing
- spatial neglect rehabilitation
- motion sickness desensitization
Neural Impact
5 of 7 neural bands affected
Drag to rotate. Click a region to learn more.
Click or hover over a glowing region to see the attack techniques targeting it and their severity.
DSM-5-TR Diagnostic Mappings
Diagnostic category references for threat modeling, not diagnostic claims.
Pathway: I0 (mastoid electrodes) → N1 (vestibular nerve) → N3 (vestibular nuclei) → N4 (cortical integration)
Following Poldrack (2006), brain region disruption does not uniquely predict psychiatric outcomes.
Scoring
NISS:1.1/BI:L/CR:N/CD:H/CV:E/RV:T/NP:T Governance
Neurorights at Risk
This technique threatens 4 of the 4 proposed neurorights (Ienca & Andorno, 2017).
FDORA §3305 Compliance
- ! CVSS cannot express neural-specific impacts
- ! Threat not yet in regulatory threat catalogs
Population Vulnerability
CRB vulnerability adjustment (γ=0.30) accounts for age, diagnosis severity, consent capacity, and device dependency.
| Population | NISS Base | Adjusted | Severity | Delta |
|---|---|---|---|---|
| Adult (Default) | 4.0 | 4.0 | Medium | - |
| Child (10yr) + ADHD | 4.0 | 4.7 | Medium | +0.71 |
| Adult with ALS | 4.0 | 4.6 | Medium | +0.64 |
Validation Status
Theoretical / Not yet validated. This technique has not been independently tested. See the validation dashboard for what has been tested.